Neuropace (NPCE): Orbimed Advisors LLC reduced its stake -792K shares
Orbimed Advisors LLC reduced its stake in Neuropace, per its Q2 2025 13F.
- 2.61M
- Shares reported · -792K vs prior quarter
- 0.73%
- Disclosed portfolio weight
- $29.1M
- Reported value
- Holdings as of
- Jun 30, 2025
- Filed
- Aug 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
- Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 6, 2025Federal contract · $19K obligatedDepartment of Health and Human Services awarded NeuroPace Inc: $19K obligated to date
- Nov 21, 2025Federal contract · $47K obligatedDepartment of Veterans Affairs awarded NeuroPace Inc: $47K obligated to date
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Neuropace
For Neuropace, OQRO holds 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NPCE page.
How this filing works
Explore the data
Common questions
What does this filing report about Neuropace (NPCE) stock?
Orbimed Advisors LLC reduced its stake in Neuropace, per its Q2 2025 13F. Now 2.61M shares, $29.1M reported value, 0.73% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2025. Filed: Aug 14, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Neuropace recently?
For Neuropace, OQRO holds 1 federal contract award dated in the last 90 days. They are listed on the NPCE page.
Does this mean NPCE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Neuropace
- USAspending.gov award recordOct 5, 2026
- SEC Form 13F-HRAug 14, 2026
- USAspending.gov award recordJun 9, 2026
- SEC Form 13F-HRMay 15, 2026
- USAspending.gov award recordMar 17, 2026
- USAspending.gov award recordMar 11, 2026
Everything OQRO holds on this company is on its NPCE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data